• 1224 Citations
  • 17 h-Index
20052019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Dario Sangiolo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Cytokine-Induced Killer Cells Medicine & Life Sciences
Adoptive Immunotherapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
T-cells Chemical Compounds
Sarcoma Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Cell Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

  • 1224 Citations
  • 17 h-Index
  • 56 Article
  • 5 Review article

NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives

Lo Nigro, C., Macagno, M., Sangiolo, D., Bertolaccini, L., Aglietta, M. & Merlano, M. C., Mar 2019, In : Annals of Translational Medicine. 7, 5, p. 105

Research output: Contribution to journalReview article

Antibody-Dependent Cell Cytotoxicity
Natural Killer Cells
Neoplasms
Immunotherapy
Monoclonal Antibodies

Veliparib: a new therapeutic option in ovarian cancer?

Ghisoni, E., Giannone, G., Tuninetti, V., Genta, S., Scotto, G., Aglietta, M., Sangiolo, D., Mittica, G. & Valabrega, G., May 10 2019, In : Future Oncology.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Platinum
Radio
Therapeutics
Maintenance
4 Citations (Scopus)

BRAF and MEK inhibitors increase PD-1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti–PD-1 antibody

Sanlorenzo, M., Vujic, I., Floris, A., Novelli, M., Gammaitoni, L., Giraudo, L., Macagno, M., Leuci, V., Rotolo, R., Donini, C., Basirico, M., Quaglino, P., Fierro, M. T., Giordano, S., Sibilia, M., Carnevale-Schianca, F., Aglietta, M. & Sangiolo, D., Jul 15 2018, In : Clinical Cancer Research. 24, 14, p. 3377-3385 9 p.

Research output: Contribution to journalArticle

Mitogen-Activated Protein Kinase Kinases
Melanoma
Lymphocytes
Antibodies
Recurrence
4 Citations (Scopus)

CD44v6 as innovative sarcoma target for CAR-redirected CIK cells

Leuci, V., Casucci, G. M., Grignani, G., Rotolo, R., Rossotti, U., Vigna, E., Gammaitoni, L., Mesiano, G., Fiorino, E., Donini, C., Pisacane, A., ambrosio, L. D., Pignochino, Y., Aglietta, M., Bondanza, A. & Sangiolo, D., May 4 2018, In : OncoImmunology. 7, 5, e1423167.

Research output: Contribution to journalArticle

Cytokine-Induced Killer Cells
Antigen Receptors
Sarcoma
Heterografts
Neoplasms
4 Citations (Scopus)

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.

Mesiano, G., Grignani, G., Fiorino, E., Leuci, V., Rotolo, R., D’Ambrosio, L., Salfi, C., Gammaitoni, L., Giraudo, L., Pisacane, A., Butera, S., Pignochino, Y., Basiricó, M., Capozzi, F., Sapino, A., Aglietta, M. & Sangiolo, D., Nov 2 2018, In : OncoImmunology. 7, 11, e1465161.

Research output: Contribution to journalArticle

Cytokine-Induced Killer Cells
Neoplastic Stem Cells
Sarcoma
Drug Therapy
Molecular Targeted Therapy